LPCN LPCN
Company Profile ↓Company Overview
LPCN (LPCN) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $1.98M (-82.3% YoY); net profit $-9.63M.
- Trailing 12 Months Year-on-year growth — revenue -82.3%.
- 5-Year Trend Long-term compounding — revenue CAGR -11.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -11.64% |
| 1 Year: | -82.35% |
Stock Price Performance
| 1 Year: | -30.67% |
| 6 Months: | -74.01% |
| 3 Months: | -6.87% |
| 1 Month: | -12.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.21 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -11.6% CAGR over 5 years.
- Trading 80.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | 54.99K | - | 500.00K | - | 54.99K | - | - | - | - | - | - | - | - | - |
| Operating Income | -4.12M | -2.97M | -4.28M | -6.43M | -4.70M | -7.07M | -5.82M | -3.29M | -3.02M | -4.91M | -6.14M | -4.77M | -5.40M | -2.64M | -3.16M | -2.35M | -3.17M | -3.13M | -3.35M | -2.98M | -4.60M | -4.22M | -4.38M | - | -3.11M | -2.99M | -3.53M | -3.13M | -3.53M | -2.90M | -4.34M | -3.96M | -7.04M | 3.22M | -3.29M | -2.63M | -2.09M | -2.40M | -3.36M | -3.85M |
| Net Income | -4.09M | -2.96M | -4.25M | -6.37M | -4.63M | -7.01M | -5.76M | -3.24M | -2.97M | -4.86M | -6.09M | -4.70M | -5.33M | -2.72M | -3.26M | -2.46M | -3.23M | -3.22M | -3.43M | -3.06M | -5.77M | -6.37M | -4.31M | - | -3.37M | -6.81M | -3.08M | -3.49M | -2.63M | -2.41M | -3.87M | -3.55M | -6.65M | 3.51M | -3.07M | -2.22M | -1.86M | -2.21M | -3.19M | -3.67M |
| Diluted EPS | -0.32 | -0.23 | -0.26 | -0.35 | -0.25 | -0.38 | -0.32 | -0.18 | -0.16 | -0.26 | -0.31 | -0.22 | -0.25 | -0.13 | -0.15 | -0.12 | -0.15 | -0.14 | -0.14 | -0.12 | -0.14 | -0.13 | -0.07 | - | -0.04 | -0.08 | -0.04 | -0.04 | -0.61 | -0.52 | -0.76 | -0.68 | -1.27 | 0.66 | -0.56 | -0.44 | -0.35 | -0.41 | -0.59 | -0.54 |
| R&D Expense | 3.25M | 1.92M | 3.16M | 4.73M | - | 2.67M | 2.57M | 1.51M | - | 3.08M | 4.11M | 2.05M | - | 1.38M | 1.48M | 1.42M | - | 1.95M | 1.96M | 1.71M | 2.51M | 2.27M | 2.49M | - | 1.58M | 1.46M | 2.37M | 1.89M | 2.90M | 2.10M | 3.11M | 2.52M | 2.88M | 2.82M | 1.87M | 1.59M | 1.06M | 2.14M | 2.71M | 2.76M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 7.71M | 0 | - | - | 0 | 0 | 428.03K | 164.99K | 0 | 16.14M | 500.00K | -2.85M | 11.20M | 1.98M |
| Operating Income | - | 3.88M | -10.68M | -20.48M | -18.38M | -19.19M | -21.22M | -11.33M | -12.90M | -18.00M | 3.15M | -12.12M | -17.93M | -1.16M | -10.37M |
| Net Income | -5.16K | 3.89M | -10.59M | -20.37M | -18.21M | -18.97M | -20.98M | -11.66M | -13.01M | -20.96M | -634.40K | -10.76M | -16.35M | 8.35K | -9.63M |
| Diluted EPS | - | 0.85 | -1.44 | -1.60 | -1.11 | -1.04 | -1.05 | -0.55 | -0.50 | -0.38 | -0.01 | -2.15 | -3.14 | - | -1.69 |
| R&D Expense | - | 2.28M | 5.12M | 15.48M | 12.58M | 8.08M | 11.00M | 6.46M | 7.47M | 9.75M | 7.67M | 8.56M | 10.18M | 7.35M | 8.58M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 32.44K | 5.57M | 46.11M | 27.99M | 45.38M | 27.34M | 25.33M | 20.85M | 19.66M | 25.35M | 52.48M | 37.54M | 23.00M | 22.51M | 17.01M |
| Total Equity | 1.30M | 5.32M | 44.82M | 26.36M | 41.99M | 26.02M | 18.98M | 9.43M | 6.29M | 15.34M | 45.57M | 35.63M | 20.37M | 21.00M | 14.48M |
| Cash & Equivalents | 8.57M | 5.38M | 45.26M | 27.67M | 20.01M | 5.56M | 3.21M | 8.08M | 9.73M | 19.22M | 2.95M | 3.15M | 4.77M | 6.21M | 5.21M |
| Long Term Debt | - | - | - | - | - | - | 0 | 6.93M | 3.81M | 2.26M | 1.67M | - | - | - | - |
| Total Liabilities | - | 250.03K | 1.28M | 1.63M | 3.39M | 1.33M | 6.35M | 11.42M | 13.37M | 10.01M | 6.91M | 1.91M | 2.63M | 1.51M | 2.53M |
| Current Liabilities | 7.61K | 212.81K | 1.28M | 1.63M | 3.39M | 1.33M | 6.35M | 4.49M | 4.96M | 6.58M | 5.62M | 1.68M | 2.63M | 1.51M | 2.53M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.29K | -3.18M | -8.59M | - | -15.36M | -18.28M | -16.70M | -12.08M | -11.67M | -15.30M | -4.41M | -11.97M | -11.87M | -1.22M | -9.76M |
| Investing Cash Flow | - | -12.32K | -1.21K | - | -25.02M | 3.23M | 3.13M | 11.29M | 3.00M | 3.89M | -43.78M | 14.29M | 13.08M | 2.45M | 5.89M |
| Financing Cash Flow | 30.24K | 0 | 48.48M | - | 32.72M | 605.87K | 11.23M | 10.65M | 10.32M | 20.90M | 26.92M | -2.13M | 404.57K | 209.34K | 2.87M |
| Capital Expenditure | - | -12.32K | -1.21K | -59.61K | -28.69K | -59.65K | -0 | -0 | - | - | -7.59K | -133.83K | -13.17K | -90.09K | - |
| Free Cash Flow | - | -3.19M | -8.59M | - | -15.38M | -18.34M | -16.70M | -12.08M | - | - | -4.42M | -12.10M | -11.88M | -1.31M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | 50.3% | - | - | - | - | - | -2,646.0% | -7,818.8% | - | 19.5% | -2,423.9% | 629.0% | -10.3% | -524.7% |
| Net Margin % | - | 50.4% | - | - | - | - | - | -2,724.1% | -7,883.7% | - | -3.9% | -2,151.7% | 573.6% | 0.1% | -487.1% |
| ROE % | -0.4% | 73.1% | -23.6% | -77.3% | -43.4% | -72.9% | -110.6% | -123.6% | -206.9% | -136.7% | -1.4% | -30.2% | -80.3% | 0.0% | -66.5% |
| ROCE % | - | 72.4% | -23.8% | -77.7% | -43.8% | -73.7% | -111.8% | -69.2% | -87.8% | -95.9% | 6.7% | -33.8% | -88.0% | -5.5% | -71.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LPCN
Lipocine's Postpartum Depression Trial Did Not Meet Primary Endpoint - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOcHcwR0ZXRVJscHFiaDcwc3FYMVVJeVFNR2pWRkozMGVEVHRjVnhzY3JWMnI2Q1M2aHBNaXgzOGRwM01SSnF4MFdWdDVTVG1YLU1MeGpCaWpmVmk2cmRzX0l1YWdkc1J6a1FVZEwyWlNKX1BpNUJMV1JwZmdybDNFOERYQWpqTzBxai1Jbj…
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNU3RlamlkSWVYbWZ1Vk9WV2J5WWJQbkQ2RVdnTDZhSjJpVUZ5djU3R3FVRGlkR3ZneXhKS0xTN0h1bUo0UkpZZXdpWHQ1dXIxX1J5Z1VVYzRGaWZHY1U1VGdWWUlCeERCcmNLLWtKeTdjQTRtMmt5VUhRM0huOE9sMmdDQ1FDeW1mZjJfSW…
Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE1vNlJ4MWlxMlktOTBGby1TYUVtdHRDT2g5UGtuZXR4TlJFLVlIczdtUzJJM1d3N2ExLVI1WE5JeWNfZXFaM2RfTVBSclo5RGZ5VE4yTmNsWnVlTkdmdlVrUjJyUjY5SjVUOFRKeWhLVzN0OWV2c00ycQ?oc=5" target="_blank">Lipoc…
Lipocine Inc (NASDAQ: LPCN) Share Price, LPCN Stock News, LPCN Share Price & Updates - Kalkine
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE44NExXbHZ4eUl4cmZzU3Rlb2lPVjFNX0Y4RWI2SDZkblkxYlo5b2Vjd05QY1VFemJ0TDhpQko1eUJvLVhpcFg4MHU4OXZLWW12V3RrSE1B?oc=5" target="_blank">Lipocine Inc (NASDAQ: LPCN) Share Price, LPCN Stock…
$LPCN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxObDBVd19vbzYxSU9JSDlNMEN5ZVRWTXhscFNWQk9KUlQ3SGRJRzQyaFFvcGZJVno2U3BQRWlzVGJ3d2JkdkloNEx0Vm5GcXQzT1QxR3ZzY3h1RmMxaGNuQjRGbWdMVUVNMHNaV0hXZkN6WjZUMjZobUNQcXVmRVpYWFhCMVkxSEpLMnFfMk…
LPCN Stock Crashes 78%— Here’s Why - Stocktwits
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOOXh6T2J1bEtBVGlkem5TSnpkVFk5dm5lakRNaEgyNHdsWGN5X2VxbTBjU01pZms2VE5IX2VKcmtQZ1ptWUJDV2hRbm1wX3BlNjBmemthSVRpbDZKcnhhNnk1ZHJhU2tlQTE1WFJOYmY2NDY1TGRPM1hqaE1zQ0o0SGdvTDVzYllUbmlGMk…
LPCN — Frequently Asked Questions
What is the current share price of LPCN?
As of 2026-08-05 17:25 PDT, LPCN trades at $2.17 on NASDAQ/NYSE. Its 52-week range is $1.94 to $11.26.
What is the P/E ratio of LPCN?
LPCN trades at a trailing price-to-earnings (P/E) ratio of -1.28.
What is the return on equity (ROE) of LPCN?
LPCN has a return on equity (ROE) of -66.50%. Its return on capital employed (ROCE) is -71.64%.
Is LPCN a good stock to buy?
This page provides a data-driven analysis of LPCN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.